Skip to main content
Earnings Labs
NewAmsterdam Pharma Company N.V. logo

NewAmsterdam Pharma Company N.V. (NAMS) Earnings

NASDAQ·Healthcare·Biotechnology

$18.59

-1.64%

Mkt Cap $2.29B

EPS — Estimate vs Actual

Mkt Cap

$2.29B

P/E

—

Fwd P/E

—

P/S

101.34

Rev TTM

—

EPS TTM

-$1.81